RE:Cannacords. $17 target ….Enroute To it ..2023Given the Green Shields exclusive eyecare deal, Green Shields planned and well executed growth plans to become Canada's largest healthcare company, Kits expanding service suite and the fact that it is not only disruptive but successfully so, with the huge US market waiting for its substantive entry, it's my view that Kits financial metrics will achieve Cannacords 2022 growth targets a year late.
That is , 2023 instead of Q 2022 .
Cannacords target of $17 per share will be achieved in 2023 , a year late but highly probable .